Shopping Cart 0
Cart Subtotal
USD 0

Intellipharmaceutics International Inc (IPCI) - Financial and Strategic SWOT Analysis Review

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 125

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 250

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 375

Details

Intellipharmaceutics International Inc (IPCI)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description-A detailed description of the company's operations and business divisions.

- Corporate strategy-Analyst's summarization of the company's business strategy.

- SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

- Company history-Progression of key events associated with the company.

- Major products and services-A list of major products, services and brands of the company.

- Key competitors-A list of key competitors to the company.

- Key employees-A list of the key executives of the company.

- Executive biographies-A brief summary of the executives' employment history.

- Key operational heads-A list of personnel heading key departments/functions.

- Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities-A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Intellipharmaceutics International Inc (Intellipharmaceutics) is a pharmaceutical company, which researches, develops, manufactures, and commercializes novel and generic targeted oral solid dosage pharmaceuticals. The company develops its controlled-release and targeted-release oral solid dosage drugs based on its proprietary technology, Hypermatrix, a multidimensional controlled-release drug delivery platform. Its products and product candidates are used for the treatment of various indications, including neuropathic pain, attention deficit hyperactivity disorder (ADHD), schizophrenia, bipolar disorder, major depressive disorder, hypertension, type 2 diabetes, and chronic angina. It offers a comprehensive range of services, including pre-formulation studies, design, and development through to regulatory approval. Intellipharmaceutics' is headquartered in Toronto, Ontario, Canada.

Intellipharmaceutics International Inc Key Recent Developments

Feb 22,2019 Intellipharmaceutics announces fiscal year 2018 results

Feb 04,2019 Intellipharmaceutics International names Greg Powell as New Chief Financial Officer

Jan 28,2019 Intellipharmaceutics receives extension from Nasdaq Hearings Panel

Jan 07,2019 Intellipharmaceutics Announces Research and Development Program for a Pipeline of Pharmaceutical Cannabidiol Based Products

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1-About the Company

Intellipharmaceutics International Inc-Key Facts

Intellipharmaceutics International Inc-Key Employees

Intellipharmaceutics International Inc-Key Employee Biographies

Intellipharmaceutics International Inc-Major Products and Services

Intellipharmaceutics International Inc-History

Intellipharmaceutics International Inc-Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Section 2-Company Analysis

Company Overview

Intellipharmaceutics International Inc-Business Description

Intellipharmaceutics International Inc-Corporate Strategy

Intellipharmaceutics International Inc-SWOT Analysis

SWOT Analysis-Overview

Intellipharmaceutics International Inc-Strengths

Intellipharmaceutics International Inc-Weaknesses

Intellipharmaceutics International Inc-Opportunities

Intellipharmaceutics International Inc-Threats

Intellipharmaceutics International Inc-Key Competitors

Section 3-Company Financial Ratios

Financial Ratios-Capital Market Ratios

Financial Ratios-Annual Ratios

Performance Chart

Financial Performance

Financial Ratios-Interim Ratios

Financial Ratios-Ratio Charts

Section 4-Company's Lifesciences Financial Deals and Alliances

Intellipharmaceutics International Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Intellipharmaceutics International Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

Intellipharmaceutics International Inc, Recent Deals Summary

Section 5-Company's Recent Developments

Feb 22, 2019: Intellipharmaceutics announces fiscal year 2018 results

Feb 04, 2019: Intellipharmaceutics International names Greg Powell as New Chief Financial Officer

Jan 28, 2019: Intellipharmaceutics receives extension from Nasdaq Hearings Panel

Jan 07, 2019: Intellipharmaceutics Announces Research and Development Program for a Pipeline of Pharmaceutical Cannabidiol Based Products

Nov 05, 2018: Intellipharmaceutics: Resignation of Chief Financial Officer

Oct 15, 2018: Intellipharmaceutics announces third quarter 2018 results

Jul 16, 2018: Intellipharmaceutics reports second quarter 2018 results

Jun 08, 2018: Intellipharmaceutics Receives Anticipated Additional Staff Determination Letter from NASDAQ

Apr 27, 2018: Intellipharmaceutics Files Appeal to Nasdaq Delisting Determination

Apr 16, 2018: Intellipharmaceutics Reports First Quarter 2018 Results

Section 6-Appendix

Methodology

Ratio Definitions

About GlobalData

Contact Us

Disclaimer


List Of Figure

List of Figures

Intellipharmaceutics International Inc, Performance Chart (2014-2018)

Intellipharmaceutics International Inc, Ratio Charts

Intellipharmaceutics International Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Intellipharmaceutics International Inc, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019


List Of Table

List of Tables

Intellipharmaceutics International Inc, Key Facts

Intellipharmaceutics International Inc, Key Employees

Intellipharmaceutics International Inc, Key Employee Biographies

Intellipharmaceutics International Inc, Major Products and Services

Intellipharmaceutics International Inc, History

Intellipharmaceutics International Inc, Subsidiaries

Intellipharmaceutics International Inc, Key Competitors

Intellipharmaceutics International Inc, Ratios based on current share price

Intellipharmaceutics International Inc, Annual Ratios

Intellipharmaceutics International Inc, Annual Ratios (Cont...1)

Intellipharmaceutics International Inc, Interim Ratios

Intellipharmaceutics International Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Intellipharmaceutics International Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

Intellipharmaceutics International Inc, Recent Deals Summary

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies

Products

Intellipharmaceutics International Inc, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts


Companies

Intellipharmaceutics International Inc, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts

Company Profile

Company Profile Title

Intellipharmaceutics International Inc (IPCI)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description-A detailed description of the company's operations and business divisions.

- Corporate strategy-Analyst's summarization of the company's business strategy.

- SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

- Company history-Progression of key events associated with the company.

- Major products and services-A list of major products, services and brands of the company.

- Key competitors-A list of key competitors to the company.

- Key employees-A list of the key executives of the company.

- Executive biographies-A brief summary of the executives' employment history.

- Key operational heads-A list of personnel heading key departments/functions.

- Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities-A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Intellipharmaceutics International Inc (Intellipharmaceutics) is a pharmaceutical company, which researches, develops, manufactures, and commercializes novel and generic targeted oral solid dosage pharmaceuticals. The company develops its controlled-release and targeted-release oral solid dosage drugs based on its proprietary technology, Hypermatrix, a multidimensional controlled-release drug delivery platform. Its products and product candidates are used for the treatment of various indications, including neuropathic pain, attention deficit hyperactivity disorder (ADHD), schizophrenia, bipolar disorder, major depressive disorder, hypertension, type 2 diabetes, and chronic angina. It offers a comprehensive range of services, including pre-formulation studies, design, and development through to regulatory approval. Intellipharmaceutics' is headquartered in Toronto, Ontario, Canada.

Intellipharmaceutics International Inc Key Recent Developments

Feb 22,2019 Intellipharmaceutics announces fiscal year 2018 results

Feb 04,2019 Intellipharmaceutics International names Greg Powell as New Chief Financial Officer

Jan 28,2019 Intellipharmaceutics receives extension from Nasdaq Hearings Panel

Jan 07,2019 Intellipharmaceutics Announces Research and Development Program for a Pipeline of Pharmaceutical Cannabidiol Based Products

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

READ MORE

Scope

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1-About the Company

Intellipharmaceutics International Inc-Key Facts

Intellipharmaceutics International Inc-Key Employees

Intellipharmaceutics International Inc-Key Employee Biographies

Intellipharmaceutics International Inc-Major Products and Services

Intellipharmaceutics International Inc-History

Intellipharmaceutics International Inc-Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Section 2-Company Analysis

Company Overview

Intellipharmaceutics International Inc-Business Description

Intellipharmaceutics International Inc-Corporate Strategy

Intellipharmaceutics International Inc-SWOT Analysis

SWOT Analysis-Overview

Intellipharmaceutics International Inc-Strengths

Intellipharmaceutics International Inc-Weaknesses

Intellipharmaceutics International Inc-Opportunities

Intellipharmaceutics International Inc-Threats

Intellipharmaceutics International Inc-Key Competitors

Section 3-Company Financial Ratios

Financial Ratios-Capital Market Ratios

Financial Ratios-Annual Ratios

Performance Chart

Financial Performance

Financial Ratios-Interim Ratios

Financial Ratios-Ratio Charts

Section 4-Company's Lifesciences Financial Deals and Alliances

Intellipharmaceutics International Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Intellipharmaceutics International Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

Intellipharmaceutics International Inc, Recent Deals Summary

Section 5-Company's Recent Developments

Feb 22, 2019: Intellipharmaceutics announces fiscal year 2018 results

Feb 04, 2019: Intellipharmaceutics International names Greg Powell as New Chief Financial Officer

Jan 28, 2019: Intellipharmaceutics receives extension from Nasdaq Hearings Panel

Jan 07, 2019: Intellipharmaceutics Announces Research and Development Program for a Pipeline of Pharmaceutical Cannabidiol Based Products

Nov 05, 2018: Intellipharmaceutics: Resignation of Chief Financial Officer

Oct 15, 2018: Intellipharmaceutics announces third quarter 2018 results

Jul 16, 2018: Intellipharmaceutics reports second quarter 2018 results

Jun 08, 2018: Intellipharmaceutics Receives Anticipated Additional Staff Determination Letter from NASDAQ

Apr 27, 2018: Intellipharmaceutics Files Appeal to Nasdaq Delisting Determination

Apr 16, 2018: Intellipharmaceutics Reports First Quarter 2018 Results

Section 6-Appendix

Methodology

Ratio Definitions

About GlobalData

Contact Us

Disclaimer


List Of Figure

List of Figures

Intellipharmaceutics International Inc, Performance Chart (2014-2018)

Intellipharmaceutics International Inc, Ratio Charts

Intellipharmaceutics International Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Intellipharmaceutics International Inc, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019


List Of Table

List of Tables

Intellipharmaceutics International Inc, Key Facts

Intellipharmaceutics International Inc, Key Employees

Intellipharmaceutics International Inc, Key Employee Biographies

Intellipharmaceutics International Inc, Major Products and Services

Intellipharmaceutics International Inc, History

Intellipharmaceutics International Inc, Subsidiaries

Intellipharmaceutics International Inc, Key Competitors

Intellipharmaceutics International Inc, Ratios based on current share price

Intellipharmaceutics International Inc, Annual Ratios

Intellipharmaceutics International Inc, Annual Ratios (Cont...1)

Intellipharmaceutics International Inc, Interim Ratios

Intellipharmaceutics International Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Intellipharmaceutics International Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

Intellipharmaceutics International Inc, Recent Deals Summary

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products

Intellipharmaceutics International Inc, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts


Companies

Intellipharmaceutics International Inc, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts